Results 271 to 280 of about 30,272 (291)

‘Off-the-shelf’ allogeneic CAR T cells: development and challenges

Nature Reviews Drug Discovery, 2020
Stéphane Depil, Laurent Poirot
exaly  

Advancing CAR T cell therapy through the use of multidimensional omics data

Nature Reviews Clinical Oncology, 2023
Yamei Chen, Ying Jing, Michael R Green
exaly  

An NK-like CAR T cell transition in CAR T cell dysfunction

Cell, 2021
Mª Angela Aznar, Sangya Agarwal, KENICHI ISHIYAMA   +2 more
exaly  

Technologia CAR-NK w terapii czerniaka

2022
Zarychta, Julia, Kowalczyk, Adrian, Klas, Jakub, Kluz, Natalia   +3 more
openaire  

Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade

Cancer Cell, 2021
Shivani Srivastava, Scott Furlan, Carla A Ruckstuhl   +2 more
exaly  

Beyond the storm — subacute toxicities and late effects in children receiving CAR T cells

Nature Reviews Clinical Oncology, 2021
Haneen Shalabi, Juliane Gust, Rebecca A Gardner   +2 more
exaly  

CAR-NK cells for haematological cancers

Best Practice & Research Clinical Haematology
Mohammadamin Noorafrooz, Robert Peter Gale, Ramin Noorafrooz, Sanaz Ghods   +3 more
openaire   +1 more source

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

Cell, 2023
Leyuan, Duncan M Morgan, Laura Maiorino
exaly  

Promising early results with CAR NK cells

Nature Reviews Clinical Oncology
openaire   +2 more sources

Driving CAR T-cells forward

Nature Reviews Clinical Oncology, 2016
Sarwish Rafiq, Renier J Brentjens
exaly